The New England journal of medicine, 2021-01, Vol.384 (2), p.129-139
- Bhatt, Deepak L
- Szarek, Michael
- Pitt, Bertram
- Cannon, Christopher P
- Leiter, Lawrence A
- McGuire, Darren K
- Lewis, Julia B
- Riddle, Matthew C
- Inzucchi, Silvio E
- Kosiborod, Mikhail N
- Cherney, David Z.I
- Dwyer, Jamie P
- Scirica, Benjamin M
- Bailey, Clifford J
- Díaz, Rafael
- Ray, Kausik K
- Udell, Jacob A
- Lopes, Renato D
- Lapuerta, Pablo
- Steg, P. Gabriel
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Bhatt, Deepak L
- Szarek, Michael
- Pitt, Bertram
- Cannon, Christopher P
- Leiter, Lawrence A
- McGuire, Darren K
- Lewis, Julia B
- Riddle, Matthew C
- Inzucchi, Silvio E
- Kosiborod, Mikhail N
- Cherney, David Z.I
- Dwyer, Jamie P
- Scirica, Benjamin M
- Bailey, Clifford J
- Díaz, Rafael
- Ray, Kausik K
- Udell, Jacob A
- Lopes, Renato D
- Lapuerta, Pablo
- Steg, P. Gabriel
- Titel
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- Ist Teil von
- The New England journal of medicine, 2021-01, Vol.384 (2), p.129-139
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a trial involving 10,584 patients with diabetes and chronic kidney disease, sotagliflozin resulted in fewer total deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart failure than placebo. Diarrhea, mycotic infections, and diabetic ketoacidosis occurred with sotagliflozin.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2030186Titel-ID: cdi_proquest_journals_2477703057
- Format
- –
- Schlagworte
- Adverse events, Aged, Cardiovascular diseases, Cardiovascular Diseases - epidemiology, Cardiovascular Diseases - mortality, Cerebral infarction, Confidence intervals, Congestive heart failure, Corporate sponsorship, Creatinine, Diabetes, Diabetes mellitus (non-insulin dependent), Diabetes Mellitus, Type 2 - complications, Diabetes Mellitus, Type 2 - drug therapy, Diabetic ketoacidosis, Diabetic Ketoacidosis - chemically induced, Diarrhea, Diarrhea - chemically induced, Double-Blind Method, Female, Glomerular filtration rate, Glucose, Glycosides - adverse effects, Glycosides - therapeutic use, Heart attacks, Heart failure, Hemoglobin, Hospitalization, Hospitalization - statistics & numerical data, Humans, Ketoacidosis, Kidney diseases, Male, Middle Aged, Mycoses - etiology, Myocardial infarction, Patients, Placebos, Renal Insufficiency, Chronic - complications, Renal Insufficiency, Chronic - drug therapy, Risk factors, Sodium-glucose cotransporter, Sodium-Glucose Transporter 1 - antagonists & inhibitors, Sodium-Glucose Transporter 2 Inhibitors - adverse effects, Sodium-Glucose Transporter 2 Inhibitors - therapeutic use, Statistical analysis